BRIEF-Insilico Medicine Secures $110 Million Series E Financing To Advance Ai-Driven Drug Discovery Innovation

Reuters
13 Mar
BRIEF-Insilico Medicine Secures $110 Million Series E Financing To Advance Ai-Driven Drug Discovery Innovation

March 13 (Reuters) - Value Partners Group Ltd 0806.HK:

  • INSILICO MEDICINE SECURES $110 MILLION SERIES E FINANCING TO ADVANCE AI-DRIVEN DRUG DISCOVERY INNOVATION

  • INSILICO MEDICINE -SERIES E FINANCING LED BY A PRIVATE EQUITY FUND OF VALUE PARTNERS GROUP

Source text: ID:nPnbNH150a

Further company coverage: 0806.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10